©Author(s) (or their employer(s)) 2026.
World J Gastroenterol. Mar 7, 2026; 32(9): 111199
Published online Mar 7, 2026. doi: 10.3748/wjg.v32.i9.111199
Published online Mar 7, 2026. doi: 10.3748/wjg.v32.i9.111199
Table 1 Liver graft preparation for small animal liver ex vivo machine perfusion
| Ref. | Via | Liver flush before MP |
| Kim et al[14] | PV | 10 mL of cold UW-G solution |
| Dutkowski et al[15] | PV | 2 mL + 3 mL + 1 mL of 4 °C UW solution (hydroxyethyl starch and glutathione free) |
| Compagnon et al[67] | A, PV | 25 mL of ice-cold Celsior-HES solution with 500 IU of heparin |
| Lauschke et al[16] | PV | 60 mL of HTK or Belzer MPS solutions |
| Lee et al[90] | NA | NA |
| Tan et al[91] | NA | NA |
| Xu et al[92] | NA | NA |
| Bessems et al[17] | PV | 50 mL of ringer lactate |
| Dutkowski et al[18] | PV | 2 mL + 3 mL + 1 mL of 4 °C UW solution (hydroxyethyl starch and glutathione free) |
| Tolboom et al[19] | PV | 5 mL + 5 mL of 4 °C UW solution |
| Vairetti et al[20] | PV | Oxygenated KH medium |
| Manekeller et al[21] | PV | HTK or Belzer MPS solutions |
| Stegemann et al[22] | PV | 20 mL of HTK or Custodiol-N solution at 4 °C |
| Ferrigno et al[23] | PV | Oxygenated KH medium |
| Lüer et al[24] | PV | 20 mL of HTK solution |
| Olschewski et al[25] | PV | 20 mL of Lifor organ preservation solution (at 4 °C, 12 °C and 21 °C) |
| Minor et al[26] | PV | 20 mL of HTK solution |
| Tolboom et al[27] | PV | 10 mL of saline |
| Giannone et al[28] | PV | 20 mL of cold Celsior solution (in situ) + 30 mL of cold Celsior solution |
| Perk et al[29] | PV | 10 mL of saline |
| Schlegel et al[30] | PV | 6 mL of 20 °C heparinized (1 IU/mL) saline |
| Bruinsma et al[88] | NA | Cold UW solution |
| Liu et al[31] | PV | 10 mL of 4 °C perfusate (control or defatting) |
| Carnevale et al[93] | NA | NA |
| Schlegel et al[32] | PV | 6 mL of 20 °C heparinized (1 IU/mL) saline |
| Schlegel et al[33] | PV | 6 mL of heparinized (1 IU/mL) saline at room temperature and UW solution at 4 °C |
| Bae et al[34] | PV | 200 mL of 0.9% saline |
| Niu et al[68] | A, PV | 50 mL of ice-cold ross perfusion fluid with 10 IU/mL heparin. 12 mL of cold supplemented UW solution. 20 mL of Hartmann’s solution with heparin (5 U/mL) |
| Tarantola et al[35] | PV | KH medium |
| Bruinsma et al[36] | PV | 10 mL of 21 °C 3-OMG loading solution + 10 mL of 21 °C 3-OMG loading solution |
| Ferrigno et al[37] | PV | 50 mL of modified KHB |
| Jia et al[38] | PV | Cooled saline containing 25 IU/mL heparin |
| Westerkamp et al[94] | NA | NA |
| Carbonell et al[95] | NA | NA |
| Op den Dries et al[75] | PV, HA | 5 mL of 37 °C 0.9% NaCl via PV + 5 mL of 4 °C 0.9% NaCl via SIVC + 20 mL of 4 °C 0.9% NaCl via PV + 5 mL of 4 °C 0.9% NaCl via HA |
| Okamura et al[39] | PV | 50 mL of preservation solution |
| Berardo et al[40] | PV | Ringer lactate |
| Chai et al[89] | NA | Cold UW solution until liver color changed to khaki |
| Zeng et al[41] | PV | 20 mL of 4 °C HTK solution |
| Beal et al[42] | PV | 60 mL of cold 0.9% saline with 1 mL heparin (100 U) |
| Tabka et al[69] | A, PV | 15 mL of 20 °C Ringer’s lactate or Celsior or with Celsior supplemented with 10-9 M of Ang IV |
| Xue et al[43] | PV | 20 mL of 4 °C HTK solution |
| He et al[78] | A | Approximately 10 mL of 0-4 °C saline |
| Gassner et al[70] | A, PV | 20 mL of 4 °C HTK solution (with/without 12 mmol/L glycine) |
| Zeng et al[79] | A | 2 mL of cold HTK solution with 10 IU/mL heparin |
| Jia et al[80] | A | Cold saline with 25 IU/mL of heparin |
| Oldani et al[44] | PV | 20 mL of cold IGL-1 solution with 100 IU heparin |
| Chin et al[45] | PV | 50 mL of 4 °C 0.9% NaCl |
| Gillooly et al[46] | PV | 10 CC of cold saline with 100 IU heparin |
| Martins et al[47] | PV | 4 °C Celsior solution |
| Scheuermann et al[48] | PV | 40 mL of cold UW solution |
| Claussen et al[71] | A, PV | 20 mL of 4 °C HTK solution supplemented with 12 mmol/L glycine |
| Haque et al[49] | PV | 50 mL of ice cold Ringer’s lactate with heparin |
| Schlegel et al[50] | PV | 10 mL of cold heparinized IGL-1 solution |
| Nösser et al[51] | PV | 20 mL of Ringer solution |
| Yamada et al[96] | NA | NA |
| Hu et al[52] | PV | 20 mL of 0-4 °C HTK solution |
| Von Horn and Minor[53] | PV | 60 mL of HTK solution |
| Raigani et al[54] | PV | 50 mL of ice-cold 0.9% saline |
| Yang et al[55] | PV | 2 mL of saline |
| Westerkamp et al[76] | PV, HA | 10 mL of 37 °C 0.9% NaCl via PV. 5 mL of 4 °C HTK solution via PV. 20 mL of 4 °C HTK solution via PV. 5 mL of 4 °C HTK solution via HA |
| De Vries et al[86] | NA | 60 mL of ice-cold saline |
| Liu et al[85] | HA | Heparin saline 40 mL (50 IU/L) |
| Lin et al[56] | PV | NA |
| Rigo et al[57] | PV | 10 mL of cold Celsior solution. 30 mL of cold Celsior solution. 10 mL of WEM |
| Xu et al[97] | NA | NA |
| Carlson et al[58] | PV | 20 mL of NaCl saline |
| Zhou et al[81] | A | 50 mL of 4 °C HTK solution |
| Cao et al[59] | PV | 10 mL of UW solution |
| De Stefano et al[60] | PV | 10 mL of saline or Celsior solution |
| Sun et al[61] | PV | NA |
| Jennings et al[62] | PV | 20 mL of cold 0.9% saline |
| Wang et al[72] | A, PV | 3 mL of cold HTK solution |
| Asong-Fontem et al[73] | A, PV | 50 mL of preservation solution. 20 mL of preservation solution at 5 °C ± 3 °C |
| Shi et al[77] | PV, HA | 0-4 °C heparinized saline |
| Von Horn et al[63] | PV | 60 mL of 4 °C HTK solution |
| Zhou et al[82] | A | 50 mL of 4 °C HTK solution |
| Luo et al[83] | A | 40 mL of heparinized saline (50 IU/mL) |
| Ohara et al[64] | PV | Ringer’s solution |
| Chen et al[65] | PV | 5 mL of 37 °C heparinized saline (2500 IU/mL) |
| Fukai et al[74] | A, PV | 60 mL of ice-chilled saline 25 mL of ice-chilled Belzer UW or Belzer MPS solutions |
| Hughes et al[84] | A | 80 mL of 4 °C HTK solution |
| Bai et al[98] | NA | NA |
| Von Horn et al[66] | PV | 60 mL of 4 °C HTK solution |
| Li et al[87] | NA | NaCl solution |
Table 2 Cannulation techniques for small animal liver ex vivo machine perfusion
| Ref. | Portal vein | Hepatic artery | Vena cava | Common bile duct |
| Kim et al[14]; Manekeller et al[21]; Stegemann et al[22]; Giannone et al[28]; Perk et al[29]; Bae et al[34]; Zeng et al[79]; Jia et al[80]; Gillooly et al[46]; Martins et al[47]; Haque et al[49]; Schlegel et al[50]; Cao et al[59]; Wang et al[72]; Asong-Fontem et al[73]; Li et al[87] | Yes | No or NA | No or NA | No or NA |
| Dutkowski et al[15]; Lee et al[90]; Bessems et al[17]; Olschewski et al[25]; Tolboom et al[27]; Bruinsma et al[88]; Carnevale et al[93]; Niu et al[68]; Bruinsma et al[36]; Zeng et al[41]; Beal et al[42]; Tabka et al[69]; Xue et al[43]; Gassner et al[70]; Oldani et al[44]; Nösser et al[51]; Hu et al[52]; Lin et al[56]; Xu et al[97]; Sun et al[61] | Yes | No or NA | Yes | Yes |
| Compagnon et al[67]; Westerkamp et al[94]; Op den Dries et al[75]; Okamura et al[39]; Claussen et al[71] | Yes | Yes | Yes | Yes |
| Lauschke et al[16]; Xu et al[92]; Dutkowski et al[18]; Tolboom et al[19]; Vairetti et al[20]; Ferrigno et al[23]; Lüer et al[24]; Minor et al[26]; Liu et al[31]; Tarantola et al[35]; Ferrigno et al[37]; Berardo et al[40]; He et al[78]; Chin et al[45]; Scheuermann et al[48]; Yamada et al[96]; Von Horn and Minor[53]; Raigani et al[54]; Yang et al[55]; De Vries et al[86]; Rigo et al[57]; Carlson et al[58]; De Stefano et al[60]; Jennings et al[62]; Von Horn et al[63]; Luo et al[83]; Chen et al[65]; Fukai et al[74]; Von Horn et al[66] | Yes | No or NA | No or NA | Yes |
| Tan et al[91]; Carbonell et al[95]; Chai et al[89] | No or NA | No or NA | No or NA | No or NA |
| Schlegel et al[30]; Schlegel et al[32]; Zhou et al[81]; Zhou et al[82] | Yes | No or NA | Yes | No or NA |
| Schlegel et al[33] | Yes | Yes | Yes | No or NA |
| Jia et al[38]; Shi et al[77] | Yes | Yes | No or NA | No or NA |
| Westerkamp et al[76]; Liu et al[85]; Ohara et al[64]; Hughes et al[84]; Bai et al[98] | Yes | Yes | No or NA | Yes |
Table 3 Experimental conditions and main findings in small animal liver ex vivo machine perfusion studies
| Ref. | Animal | WI time before MP | Length of SCS before MP | MP type and length of MP |
| Kim et al[14] | Rats | NA | 0 hour | HMP: 48 hours |
| Dutkowski et al[15] | Rats | 11.4 minutes 0.8 minutes or 4.2 minutes 0.4 minutes | NA | HMP: 10 hours |
| Compagnon et al[67] | Rats | < 20 seconds | NA | HMP: 24 hours or 48 hours; NMP: 2 hours |
| Lauschke et al[16] | Rats | 60 minutes | NA | HMP: 24 hours; NMP (reperfusion): 45 minutes |
| Lee et al[90] | Rats | 30 minutes | NA | HMP: 5 hours |
| Tan et al[91] | Rats | NA | 30 minutes | HMP: 36 hours |
| Xu et al[92] | Rats | NA | 0 hour (before HMP) or 24 hours (before NMP) | HMP: 24 hours; NMP: 1 hour |
| Bessems et al[17] | Rats | NA | NA | HMP: 24 hours; NMP (reperfusion): 1 hour |
| Dutkowski et al[18] | Rats | NA | 10 hours | HOPE: 3 hours; NMP (reperfusion): 40 minutes |
| Tolboom et al[19] | Rats | NA | 0 hour | NMP: 6 hours |
| Vairetti et al[20] | Rats | NA | NA | 4 °C, 10 °C, 20 °C, 25 °C, 30 °C, or 37 °C MP: 6 hours, NMP (reperfusion): 2 hours |
| Manekeller et al[21] | Rats | 30 minutes | NA | HMP: 18 hours; NMP (reperfusion): 2 hours |
| Stegemann et al[22] | Rats | 30 minutes | NA | HMP: 18 hours; NMP (reperfusion): 2 hours |
| Ferrigno et al[23] | Rats | NA | NA | HMP or SNMP: 6 hours; NMP (reperfusion): 2 hours |
| Lüer et al[24] | Rats | NA | NA | HMP: 18 hours; NMP (reperfusion): 2 hours |
| Olschewski et al[25] | Rats | 60 minutes | NA | HMP or SNMP: 6 hours; NMP (reperfusion): 6 hours |
| Minor et al[26] | Rats | 30 minutes | NA | HMP: 18 hours; NMP (reperfusion): 2 hours |
| Tolboom et al[27] | Rats | 1 hour | NA | SNMP: 5 hours; NMP: 5 hours |
| Giannone et al[28] | Rats | NA | NA | Normobaric or hyperbaric HMP: 24 hours |
| Perk et al[29] | Rats | 60 minutes or 90 minutes | NA | NMP: 6 hours |
| Schlegel et al[30] | Rats | 30 minutes | 4 hours | HMP: 1 hour |
| Bruinsma et al[88] | Rats | NA | 0 hour, 24 hours, 48 hours, 72 hours and 120 hours | SNMP: 3 hours |
| Liu et al[31] | Rats | NA | NA | SNMP: 6 hours |
| Carnevale et al[93] | Rats | 45 minutes | NA | HMP: 24 hours; NMP (reperfusion): 1.5 hours |
| Schlegel et al[32] | Rats | NA | 30 minutes | HMP or HNP: 1 hour |
| Schlegel et al[33] | Rats | 30 minutes or 60 minutes | NMP: 0 minute or 15 minutes; HOPE: 4 hours | NMP: 4 hours; HOPE: 1 hour |
| Bae et al[34] | Rats | 30-40 minutes | NA | HMP: 8 hours; NMP (reperfusion): 90 minutes |
| Niu et al[68] | Rats | 60 minutes | 5 hours | NMP: 2 hours |
| Tarantola et al[35] | Rats | NA | 6 hours | SNMP, NMP (reperfusion): 6 hours |
| Bruinsma et al[36] | Rats | NA | NA | Loading SNMP: 80 minutes; supercooling: 3-4 days; recovery SNMP: 5 hours |
| Ferrigno et al[37] | Rats | NA | NA | 10 °C, 20 °C, 30 °C or 37 °C MP: 6 hours |
| Jia et al[38] | Rats | NA | 0 hour or 6 hours | HMP: 6 hours or 0 hour |
| Westerkamp et al[94] | Rats | 30 minutes | 6 hours | HMP or SNMP or rewarming MP: 1 hour; NMP: 2 hours |
| Carbonell et al[95] | Rats | NA | NA | NMP: 15 minutes to stabilize (all groups); SNMP or NMP: 30 minutes |
| Op den Dries et al[75] | Rats | 0 minute or 30 minutes | 0 hour or 3 hours | NMP: 3 hours; NMP (reperfusion): 2 hours |
| Okamura et al[39] | Rats | NA | NA | SNMP: 4 hours; NMP: 2 hours |
| Berardo et al[40] | Rats | NA | 6 hours | SNMP: 6 hours; NMP: 2 hours |
| Chai et al[89] | Rats | NA | NA | HMP: 2 hours or 12 hours |
| Zeng et al[41] | Rats | 30 minutes | NA | HMP: 3 hours; NMP (reperfusion): 2 hours |
| Beal et al[42] | Rats | NA | NA | NMP: 4 hours |
| Tabka et al[69] | Rats | NA | NA | SNMP: 6 hours; NMP (reperfusion): 2 hours |
| Xue et al[43] | Rats | 30 minutes | NA | HMP: 3 hours; NMP: 1 hour |
| He et al[78] | Rats | NA | NA | HMP: 3 hours or 6 hours |
| Gassner et al[70] | Rats | 30 minutes | NA | NMP: 6 hours |
| Zeng et al[79] | Mice | 30 minutes | 4 hours | HOPE or HNPE: 1 hour; NMP (reperfusion): 2 hours |
| Jia et al[80] | Rats | NA | NA | HMP: 6 hours |
| Oldani et al[44] | Rats | 1 hour | 30 minutes | HOPE or NMP: 2 hours |
| Chin et al[45] | Rat | NA | NA | NMP: 6 hours |
| Gillooly et al[46] | Rats | 25 minutes | NA | HMP, NMP: 4 hours |
| Martins et al[47] | Rats | NA | 12 hours | NMP: 1 hour |
| Scheuermann et al[48] | Rats | NA | 0 hour | SNMP or NMP: 4 hours; NMP (reperfusion): 2 hours |
| Claussen et al[71] | Rats | < 15 minutes | < 60 minutes | NMP: 6 hours |
| Haque et al[49] | Rats | NA | NA | NMP: 24 hours |
| Schlegel et al[50] | Rats | 30 minutes | 4 hours | NMP or HOPE: 1 hour |
| Nösser et al[51] | Rats | NA | 81.71 minutes ± 28.44 minutes | SNMP or NMP: 6 hours or 12 hours |
| Yamada et al[96] | Rats | 30 minutes | 6 hours | SNMP or NMP: 30 minutes, 60 minutes or 90 minutes |
| Hu et al[52] | Rats | 30 minutes | NA | HMP: 1 hour, 3 hours, 4 hours, 12 hours, 24 hours; NMP: 2 hours |
| Von Horn and Minor[53] | Rats | 20 minutes | 18 hours | NMP: 2 hours |
| Raigani et al[54] | Rats | NA | < 10 minutes | NMP: 6 hours |
| Yang et al[55] | Rats | 30 minutes | NA | NMP: 8 hours |
| Westerkamp et al[76] | Rats | NA | 4 hours | NMP: 3 hours |
| De Vries et al[86] | Rats | 0 h | 0 hour or 24 hours or 72 hours | SNMP: 3 hours |
| Liu et al[85] | Rats | 0 minute, 10 minutes or 30 minutes | NA | HMP or NMP: 4 hours |
| Lin et al[56] | Rats | NA | 1 hour | HMP: 3 hours |
| Rigo et al[57] | Rats | 3.10 minutes (0.35) mean (SEM) | NA | NMP: 4 hours |
| Xu et al[97] | Rats | NA | NA | NMP: 4 hours |
| Carlson et al[58] | Rats | NA | < 5 minutes | NMP: 4 hours |
| Zhou et al[81] | Rats | 30 minutes | 23 hours | HOPE: 1 hour; NMP: 1 hour |
| Cao et al[59] | Rats | 30 minutes | NA | NMP: 4 hours |
| De Stefano et al[60] | Rats | 60 minutes | No or 34 minutes ± 7 minutes | NMP: 6 hours |
| Sun et al[61] | Rats | 30 minutes | NA | NMP: 6 hours |
| Jennings et al[62] | Rats | NA | < 5 minutes | NMP: 4 hours |
| Wang et al[72] | Mice | 10 minutes | 11 hours | HOPE: 1 hour; NMP (reperfusion): 2 hours |
| Asong-Fontem et al[73] | Rats | NA | 24 hours | HOPE: 2 hours; NMP (reperfusion): 2 hours |
| Shi et al[77] | Rats | 30 minutes | 8 hours | NMP: 2 hours |
| Von Horn et al[63] | Rats | 20 minutes | 17 hours or 18 hours | HMP: 1 hour; NMP (reperfusion): 2 hours |
| Zhou et al[82] | Rats | 30 minutes | 0 hour or 23 hours | HOPE: 1 hour; NMP: 1 hour |
| Luo et al[83] | Rats | 30 minutes | 3 hours or 4 hours | HMP or HOPE: 1 hour; NMP: 2 hours |
| Ohara et al[64] | Rats | 60 minutes | NA | NMP: 4 hours |
| Chen et al[65] | Mice | NA | NA | NMP: 12 hours |
| Fukai et al[74] | Rats | 30 minutes | NA | HMP: 3 hours; NMP (reperfusion): 90 minutes |
| Hughes et al[84] | Rats | 30 minutes | During MP priming | NMP: 4 hours |
| Bai et al[98] | Rats | 30 minutes | 8 hours | NMP: 2 hours |
| Von Horn et al[66] | Rats | 20 minutes | 18 hours | Rewarming MP: 2 hours; NMP: 1 hour |
| Li et al[87] | Rats | NA | NA | NMP: 3 hours |
Table 4 Perfusate compositions in small animal liver ex vivo machine perfusion studies
| Ref. | Animal weight | Liver weight | Perfusate volume | Perfusate composition |
| Kim et al[14] | 200-400 g | NA | 200 mL | Cold UW-G solution |
| Dutkowski et al[15] | 250-300 g | 10.4 ± 0.3 g | 500 mL | Modified UW solution: Starch and glutathione was omitted, supplemented with 80 mg/L gentamycin, and 5000 IU/L heparin |
| Compagnon et al[67] | 300 ± 50 g | NA | 150 mL | HMP: Celsior-HES solution. NMP: KHB buffer with 5% bovine serum albumin |
| Lauschke et al[16] | 250-300 g | NA | 125 mL | HMP: HTK or Belzer MPS solution supplemented with 6000 IU superoxide dismutase. NMP: KH buffer |
| Lee et al[90] | 200-250 g | NA | 100 mL | KH solution, then switched to UW solution (starch omitted) |
| Tan et al[91] | 180-220 g | NA | 120 mL | Modified Hoffmann perfusate: Hydroxyethyl starch 50 g/L, calcium gluconate 80 mmol/L, raffinose 10 mmol/L, KH2PO4 25 mmol/L, hydroxyethyl piperazine 10 mmol/L, dexamethasone 12 mg/L, penicillin 2 × 105 units/L, insulin 100 units/L, and with/without 25 mmol/L MgCl and/or 5 mmol/L ATP |
| Xu et al[92] | 200-250 g | NA | NA | HMP: UW solution with/without starch. NMP: KH buffer solution containing 112 μmol/L taurocholic acid, and 150 μg/L hyaluronic acid |
| Bessems et al[17] | 350 ± 50 g | 16.5 ± 0.5 g | 250 mL | HMP: The UW-G solution or polysol. NMP: KHB without bovine serum albumin |
| Dutkowski et al[18] | 250-300 g | 10.8 ± 1.4 g | 450 mL | HOPE: Modified starch-free UW solution. NMP: KHB buffer |
| Tolboom et al[19] | 250-300 g | 9.74-0.81 g | 55-60 mL | NMP: Phenol red-free WEM supplemented with 2 IU/L insulin, 40000 IU/L penicillin, 40000 mg/L streptomycin, 0.292 g/L L-glutamine, 10 mg/L hydrocortisone, 1000 IU/L heparin with 25% (v/v) freshly isolated rat plasma and freshly isolated rat erythrocytes to a hematocrit of 16% to 18% |
| Vairetti et al[20] | 250-300 g | NA | 200 mL | KH solution with 1.25 mmol/L CaCl2 or with 0.25 mmol/L CaCl2 |
| Manekeller et al[21] | 250-300 g | NA | 125 mL | HMP: HTK or Blezer MPS solutions. NMP: KH buffer |
| Stegemann et al[22] | 250-300 g | NA | HMP: 125 mL; NMP: 250 mL | HMP: HTK or modified HTK solution (custodiol-N). NMP: KH buffer with 3 g/100 mL of bovine serum albumin |
| Ferrigno et al[23] | 375 ± 15 g and 300 ± | NA | 200 mL | KH medium |
| Lüer et al[24] | 250-300 g | NA | 125 mL | HMP: HTK solution. NMP: WEM solution, supplemented with 3 mg/100 mL of bovine serum albumin |
| Olschewski et al[25] | 250-280 g | NA | NA | HMP, SNMP: Lifor solution. NMP: KH solution |
| Minor et al[26] | 250-300 g | NA | HMP: 125 mL; NMP: 250 mL | HMP: HTK solution supplemented with 0 μmol/L, 10 μmol/L, 50 μmol/L or 100 μmol/L of dopamine. NMP: WEM solution with 3 mg/100 mL of bovine serum albumin |
| Tolboom et al[27] | 250-300 g | NA | 55-60 mL | WEM with autologous erythrocytes and plasma. To this were added: Insulin (2 IU/L), penicillin (40000 IU/L)/streptomycin (40000 μg/L), L-glutamine (0.292 g/L), hydrocortisone (10 mg/L), and heparin (1000 IU/L) |
| Schlegel et al[30] | 250-300 g | 9.83 ± 0.95 g | 50 mL | Modified starch free UW-solution |
| Giannone et al[28] | 250-300 g | NA | NA | Celsior solution |
| Perk et al[29] | 200-300 g | NA | 55-60 mL | Phenol red-free WEM supplemented with 2 IU/L insulin (28.85 units/mg), 100000 IU/L penicillin, 100 mg/L streptomycin sulfate, 0.292 g/L L-glutamine, 10 mg/L hydrocortisone, and 1000 IU/L heparin. Fresh rat plasma (25% v/v) and erythrocytes (18%-20% v/v) were collected and added to the perfusate |
| Bruinsma et al[88] | 180-250 g | NA | 500 mL | WE supplemented with insulin (2 IU/L), penicillin (40000 IU/L)/streptomycin (40000 μg/L), L-glutamine (0.292 g/L), hydrocortisone (10 mg/L) |
| Liu et al[31] | NA | 21.4 ± 3.6 g (control) 22.9 ± 5.8 g (defatting group) | 200 mL | The control perfusate: Minimum essential medium supplemented with 3% wt/vol bovine serum albumin, 1.07 mmol/L lactic acid, and 0.11 mmol/L pyruvic acid. The defatting perfusate: The control perfusate supplemented with the 6 defatting agents (forskolin, GW7647, scoparone, hypericin, visfatin, and GW501516) |
| Carnevale et al[93] | 250-300 g | NA | 250 mL | HMP: HTK solution: 100 mmol/L sodium gluconate, 7 mmol/L potassium gluconate, 20 mmol/L sucrose, 30 mmol/L BES, 2.5 mmol/L KH2PO4, and 0.03 mmol/L polyethylene glycol (35 kDa), 5 mmol/L MgSO4, 3 mmol/L glutathione, 5 mmol/L adenosine, and 15 mmol/L glycine, together with 0.25 mg/mL streptomycin and 10 IU/mL penicillin G. NMP: KH buffer with 4% dextran added |
| Schlegel et al[32] | 250-320 g | 9.7 ± 1.5 g | 50 mL | Modified starch free UW-solution |
| Schlegel et al[33] | 250-320 g | 10.14 ± 2.73 g | 50 mL | NMP: Diluted full blood or leukocyte and platelet depleted blood perfusate. HOPE: Modified starch-free UW solution |
| Bae et al[34] | 300 ± 25 g | NA | 100 mL | HMP: KPS-1 solution (Identical to Belzer’s UW MPS) or KPS-1, enhanced with α-ketoglutarate, L-arginine, N-acetylcysteine, nitroglycerin, and prostaglandin E1 or KPS-1, with 5.4 × 10-2 mmol/L of α-tocopherol diluted in acetone. NMP: KHB buffer |
| Niu et al[68] | 261 ± 4 g | NA | 353 ± 11 mL | KH buffer |
| Tarantola et al[35] | 375 ± 15 g and 300 ± | NA | 200 mL | KH medium |
| Bruinsma et al[36] | 250-300 g | Approximately 10 g | 100 mL | 3-OMG loading solution: 500 mL phenol-red free WEM, 5 mL of 200 mmol/L L-glutamine (0.292 mg/L), 4 mL of penicillin-streptomycin (5000 IU/mL), 5 mg of hydrocortisone, 5000 U of sodium heparin, 375 U of insulin, 19.42 g of 3-O-methyl glucose (0.2 M) |
| Ferrigno et al[37] | 250-300 g | NA | NA | A modified KH buffer |
| Jia et al[38] | 250-300 g | NA | 60 mL | UW or HTK solutions |
| Westerkamp et al[94] | 290-320 g | NA | 100 mL | HMP, SNMP, rewarming MP: Belzer MPS. NMP: 25 mL of human red blood cell concentrate (final hematocrit 25%), 53.9 mL of WEM solution, 20 mL of human albumin (200 g/L), 1 mL of insulin (100 IU/mL), and 0.1 mL of unfractionated heparin (5000 IU/mL) |
| Carbonell et al[95] | 225-250 g | NA | NA | KH buffer: 118 mmol/L NaCl, 4.7 mmol/L KCl, 1.2 mmol/L MgSO4, 1.2 mmol/L KH2PO4, 2.5 mmol/L CaCl2, 25 mmol/L NaHCO3, 20 mmol/L HEPES |
| Op den Dries et al[75] | 303 ± 4 g (mean ± SEM) | 100 mL | 20 mL of human red blood cell concentrate (final hematocrit 15%-20%), 59 mL of WEM solution, 20 mL of human albumin (200 g/L), 1 mL of insulin (100 IU/mL), and 0.1 mL of unfractionated heparin (5000 IU/mL) | |
| Okamura et al[39] | 250-300 g | NA | 300 mL | SNMP: Polysol solution. NMP: KH buffer |
| Berardo et al[40] | 250-300 g | NA | NA | KH buffer |
| Chai et al[89] | 250-300 g and 600-630 g | NA | 80 mL | UW solution with/without 0.165 mg/L of metformin |
| Zeng et al[41] | 250-300 g | NA | 150 mL | HTK solution |
| Beal et al[42] | 250-350 g | NA | 300 mL | 86 mL of 25% albumin, 184 mL of WEM, 30 mL of penicillin/streptomycin (10 IU/mL penicillin and 0.01 mg/mL streptomycin), insulin (50 IU/L), heparin (0.01 IU/mL), L-glutamine (0.292 g/L), and hydrocortisone (0.010 g/L). Addition of 625 IU/mL pegylated-catalase |
| Tabka et al[69] | 250-300 g | NA | SNMP: 150 mL; NMP: 140 mL | SNMP: Celsior with/without Ang IV. NMP: KBB enriched with 5% albumin |
| Xue et al[43] | 250 ± 10 g | NA | HMP: 100 mL; NMP: 250 mL | HMP: HTK solution. NMP: KH buffer with 4% dextran |
| He et al[78] | 250-300 g | NA | NA | HTK solution |
| Gassner et al[70] | 280-350 g | 13.6 g ± 2.15 g | 50 mL | NMP: Low-glucose DMEM supplemented with the rat erythrocyte concentrate and 12.5 mL strain specific rat plasma |
| Zeng et al[79] | 20-24 g | NA | 50 mL | HTK solution |
| Jia et al[80] | 250-300 g | NA | 60 mL | HTK solution |
| Oldani et al[44] | 176 (155-193) g | NA | 50 mL | HOPE: IGL-1 solution with 150 IU heparin. NMP: 25 mL Fischer rat blood with 25 mL normal saline, and with 150 IU heparin |
| Chin et al[45] | 200-250 g | NA | 150 mL | DMEM supplemented with 200 mmol/L L-glutamine, 10% v/v FBS, 5% with bovine serum albumin, 8 mg/L dexamethasone, 2000 IU/L heparin, 2 IU/L insulin, and 5 × 106 engineered rat fibroblasts |
| Gillooly et al[46] | Approximately 300 g | NA | 100 mL | 99 mL WEM with 10 IU insulin, and lipid nanoparticles (50 nM siRNA) |
| Martins et al[47] | 320-350 g | NA | NA | 50% plasma-Lyte and 50% KH solution |
| Scheuermann et al[48] | 296 g ± 8 g (mean ± SEM) | NA | 100 mL | SNMP, NMP: 80 mL of WEM supplemented with 5% bovine serum albumin, 20 mL of type O + human RBCs, 0.2 IU insulin, 29.2 mg L-glutamine, 1 mg hydrocortisone, and 500 IU heparin. NMP: KH buffer supplemented with 5% bovine serum albumin |
| Claussen et al[71] | 280-350 g | NA | 50 mL | 10 mL of the erythrocyte concentrate, 35 mL of DMEM, 5 mL of strain specific rat plasma supplemented with 1000 IU heparin and 12 mmol/L glycine |
| Haque et al[49] | 250-300 g | NA | 500 mL | NMP: 950 mL of William’s E media, 20 g of bovine serum albumin, 20 g of polyethylene glycol 35000, 20 mg of dexamethasone, 2 mL of heparin, 1 mL of regular insulin, 10 mL penicillin-streptomycin, 10 mL of antibiotic-antimycotic, and 2.2 g of sodium bicarbonate |
| Schlegel et al[50] | 250-320 g | 9.8 0.6 g | 100 mL | HOPE: Belzer MPS. NMP: Belzer MPS or diluted heparinized blood |
| Nösser et al[51] | 398.87 ± 133.12 g | 14.15 ± 2.66 g | 250 mL, 100 mL, 80 mL, 50 mL | SNMP: 500 Ml DMEM supplemented with 100 μg/mL penicillin and streptomycin, 4 mmol/L L-glutamine/L-alanine, 1 μM human insulin, 14 ng/mL glucagon, 1 μM dexamethasone. NMP: The isolated RBCs suspended in DMEM, isolated rat plasma (10% of the total volume), and 500 IU of heparin |
| Yamada et al[96] | 260-350 g | DCD 10.12 ± 0.93 g | NA | KH buffer |
| Hu et al[52] | 250-300 g | NA | 150 mL | HTK solution |
| Von Horn and Minor[53] | 250-300 g | NA | 200 mL | Aqix RS-I solution |
| Raigani et al[54] | NA | NA | 500 mL | High-glucose DMEM supplemented with 10% v/v FBS, 2% v/v penicillin-streptomycin, and 3% w/v bovine serum albumin. Defatting cocktail agents include 10 μM forskolin, 1 μM GW7647, 1 μM GW501516, 10 μM scoparone, 10 μM hypericin, 0.4 ng/mL visfatin, 0.8 mmol/L L-carnitine, and additional amino acids |
| Yang et al[55] | 200-220 g | NA | NA | 60 mL DMEM/F12 (1:1) containing 20% FBS and 1% penicillin-streptomycin solution (penicillin 10000 IU/mL, streptomycin 10000 μg/mL), 20 mL of fresh blood, 5 IU/mL of heparin, 2 IU/L of insulin, and 2.5 μg/mL of dexamethasone |
| Westerkamp et al[76] | 270-300 g | NA | 100 mL | 25 mL human red blood cell concentrate, 53.9 mL WEM solution, 20 mL human albumin (200 g/L), 1 mL insulin (100 IU/mL), and 0.1 mL unfractionated heparin (5000 IU/mL) |
| De Vries et al[86] | 200-250 g | NA | 500 mL | WEM supplemented with sodium bicarbonate (2.2 g/L), dexamethasone (24 mg/L), insulin (5 IU/L), heparin (2000 IU/L), and bovine serum albumin (10 mg/mL) |
| Liu et al[85] | NA | NA | 70 mL | HMP: UW solution with 250 IU heparin, 20000 IU penicillin and 2 mg hydrocortisone. Addition of CIRP competitive inhibitor (C23, 300 ng/mL). NMP: 20 mL rat blood, 50 mL WEM, 250 IU heparin, 20000 IU penicillin, 2 mg hydrocortisone, 0.4 IU insulin, and 0.0292 g glutamine |
| Lin et al[56] | 180 ± 20 g | NA | 50 mL | HTK solution with or without various defatting agents (10 mmol/L forskolin; 1 mmol/L GW7647; 10 mmol/L hypericin; 10 mmol/L scoparone; 0.4 ng/mL visfatin; 1 mmol/L GW501516) |
| Rigo et al[57] | 200-250 g | 10.35 g (0.41) mean (SEM) | 70 mL | NMP: 20 mL of fresh rat blood, 50 mL of complete phenol red-free WEM, supplemented with 11.6 mmol/L glucose, 50 IU/mL penicillin, 50 μg/mL streptomycin, 5 mmol/L L-glutamine, 1 IU/mL insulin, 1 IU/mL heparin, and 2 mEq of sodium bicarbonate |
| Xu et al[97] | Approximately 500 g | Approximately 15 g | 60-110 mL | Whole blood-based perfusate with different defatting components |
| Carlson et al[58] | 331 ± 16 g (mean ± SEM) | NA | 95 mL | WEM, 3250 IU each penicillin/streptomycin, 0.65 mmol/L sodium pyruvate, 1.30 mmol/L L-glutamine, 1% human albumin, 500 IU heparin, 15 mg papaverine, 1 mg insulin, 1.25 mg hydrocortisone, and 30 mL of leukoreduced, packed RBCs |
| Zhou et al[81] | 250-300 g | NA | NA | NA |
| Cao et al[59] | 200-220 g | NA | 80 mL | DMEM/F12, 20 mL rat blood, 100 IU/mL penicillin, 100 μg/mL streptomycin, and 5 IU/mL heparin |
| De Stefano et al[60] | 200-250 g | Control group: 17.10 (1.93). WI group: 15.17 (0.83) | 150 mL | 100 mL of phenol red-free WEM, supplemented with 100 IU/mL penicillin, 100 μg/mL streptomycin, 0.292 g/L L-glutamine, 1 IU/mL insulin, 1 IU/mL heparin, and 50 mL of recently expired (max 5 days) human red blood cell |
| Sun et al[61] | 200-220 g | NA | 2 mL | Normal saline or single cell suspension containing 1× 107-3 × 107 BMMSCs |
| Jennings et al[62] | 320 ± 11 g (mean ± SEM) | NA | 130 mL or 146 mL | WEM (65 mL for pRBC oxygen carriers and 50 mL for oxyglobin) with 3250 U each penicillin/streptomycin, 500 U heparin, 1 mg insulin, 1.25 mg hydrocortisone, and 15 mg papaverine. In addition, sodium pyruvate 0.65 mmol/L, L-glutamine 130 mmol/L, and human albumin 1%. The oxygen carriers added to the perfusate were human pRBC (30 mL), rat pRBC (30 mL), or oxyglobin (46 mL) |
| Wang et al[72] | NA | NA | HOPE: 50 mL; NMP: 30 mL | HOPE: HTK solution. NMP: 7.5 mL blood, 22.5 mL KHB solution containing 2% FBS, 60 mg glucose, 1 IU insulin, and 150 IU heparin |
| Asong-Fontem et al[73] | NA | NA | NA | HOPE: IGL-2 or PERF-GEN (Belzer MPS) solutions. NMP: Williams medium E supplemented with insulin 2 U/L, penicillin (40000 U/L)/streptomycin (40000 μg/L), L-glutamine, hydrocortisone 10 mg/L and heparin (1000 U/L) |
| Shi et al[77] | 320-350 g | NA | 36 mL | 24 mL whole heparinized blood supplemented with 10% sodium citrate, 1% penicillin and streptomycin, and 12 mL circuit priming solution with 45% lactated ringer, 5% sodium bicarbonate and 50% hydroxyethyl starch |
| Von Horn et al[63] | 250-300 g | NA | 150 mL | HMP: Aqix RS-I solution. NMP: WEM supplemented with 3 mg/100 mL of bovine serum albumin |
| Zhou et al[82] | 250-300 g | NA | NA | NA |
| Luo et al[83] | 250-300 g | NA | HMP: 150 mL; NMP: 180 mL | HMP: HTK solution. NMP: DMEM/F12, 20% FBS, 1% penicillin streptomycin solution (penicillin 10000 IU/mL, streptomycin 10000 mg/mL), 5 IU/mL of heparin, 2 IU/L of insulin, and 2.5 mg/mL of dexamethasone. Full rat blood (30-45 mL) was reconstituted up to a total volume of 180 mL perfusate |
| Ohara et al[64] | 250-350 g | NA | 100 mL | Rat whole blood |
| Chen et al[65] | 34 ± 4 g (mean ± SEM) | Approximately 1 g | 300 mL | WEM was supplemented with 20% FBS, 1% penicillin/streptomycin, 5000 IU/L heparin, 50 IU/L insulin, and 0.010 g/L hydrocortisone |
| Fukai et al[74] | NA | NA | 300 mL | HMP: UW-MPS solution. NMP: KHB solution |
| Hughes et al[84] | 250-300 g | 14 ± 0.2 g | 150 mL | Phenol red-free WEM with addition of 25% bovine albumin, rat RBCs, 2 IU/L insulin, 40000 IU/L penicillin, 40000 μg/L streptomycin, 0.292 g/L L-glutamine, 10 mg/L hydrocortisone, 1000 IU/L heparin, and bicarbonate 75% |
| Bai et al[98] | 360-380 g | NA | 36 mL | 24 mL whole heparinized blood supplemented with 10% sodium citrate, 1% penicillin, and streptomycin and 12 mL circuit priming solution with 45% lactated ringer, 5% sodium bicarbonate, and 50% hydroxyethyl starch |
| Von Horn et al[66] | 250-300 g | NA | NA | Rewarming MP: Diluted Steen solution or Belzer MPS. NMP: WEM supplemented with 3 mg/100 mL of bovine serum albumin |
| Li et al[87] | 250-350 g | NA | 100 mL | 90 mL WEM with 10 mL rat blood cells supplemented with 10 mg/L hydrocortisone, 5 IU/mL heparin, 1 IU/mL insulin, 5 mmol/L L-glutamine, 40 IU/mL penicillin, 40 μg/mL streptomycin, and with/without 10 mmol/L epigallocatechin gallate |
Table 5 Parameters used in small animal liver ex vivo machine perfusion studies
| Ref. | HMP | SNMP | NMP | ||||||
| Temperature | Flow | Pressure | Temperature | Flow | Pressure | Temperature | Flow | Pressure | |
| Kim et al[14] | 4 °C | 0.5 mL/minute/g liver | 11.2 ± 0.4 mmHg | ||||||
| Dutkowski et al[15] | 3-6 °C | 0.43-0.44 mL/minute/g liver | 4.48-0.47 mmHg | ||||||
| Compagnon et al[67] | 4 °C | 0.1-0.4 mL/minute/g liver | PV, VC: ≤ 1 mmHg; HA: ≤ 11 mmHg | 37 °C | 3 mL/minute/g wet liver | NA | |||
| Lauschke et al[16] | 4 °C | 0.5 mL/minute/g | NA | 37 °C | 3 mL/g/minute | NA | |||
| Lee et al[90] | 4-5 °C | 0.4 mL/minute/g liver | < 3 mmHg | ||||||
| Tan et al[91] | 6-8 °C | 0.1 mL/minute/g | NA | ||||||
| Xu et al[92] | 4 °C | 0.4 mL/minute/g liver | NA | 37 °C | NA | NA | |||
| Bessems et al[17] | 4 °C | < 1 mL/minute/g liver | < 20 | 37.1 °C ± 0.4 °C | < 3 mL/minute/g liver | < 20 | |||
| Dutkowski et al[18] | 3-5 °C | 2.75-3.25 mL/minute | 4.4 ± 0.5 mmHg | 37 °C | 15 mL/minute | NA | |||
| Tolboom et al[19] | 37.5 °C | 1.8 mL/ minute/g ± 0.12 mL/ minute/g wet liver | 12-15 cmH2O | ||||||
| Vairetti et al[20] | 4 °C, 10 °C | NA | NA | 20 °C, 25 °C, 30 °C | NA | NA | 37 °C | Initial: 1 mL/minute/g, increased to 4 mL/minute/g | NA |
| Manekeller et al[21] | 4 °C | NA | NA | 37 °C | 3 mL/g/minute | NA | |||
| Stegemann et al[22] | 4 °C | 0.5 mL/minute/g | NA | 37 °C | 3 mL/g/minute | NA | |||
| Ferrigno et al[23] | 4 °C or 8 °C | 4 mL/minute/g | 7.4 ± 0.6 mmHg (lean, 4 °C), 8.7 ± 2.1 mmHg (fat, 4 °C), 6.9 ± 0.8 mmHg (lean, 8 °C), 7.1 ± 0.9 mmHg (fat, 8 °C) | 20 °C | 4 mL/minute/g | 7.3 ± 0.8 mmHg (lean) 7.5 ± 1.6 mmHg (fat) | 37 °C | 4 mL/minute/g | NA |
| Lüer et al[24] | 4 °C | 0.5 mL/minute/g | NA | 37 °C | 3 mL/g/minute | NA | |||
| Olschewski et al[25] | 4 °C or 12 °C | 1 mL/minute/g liver | NA | 21 °C | 1 mL/minute/g liver | NA | 37 °C | 3 mL/minute/g liver | NA |
| Minor et al[26] | 4 °C | 0.5 mL/minute/g | NA | 37 °C | 3 mL/g/minute | NA | |||
| Tolboom et al[27] | 20 °C or 30 °C or 37 °C | 2 mL/minute/g | 10-14 cmH2O | 37 °C | 2 mL/minute/g | 10-14 cmH2O | |||
| Giannone et al[28] | 4 °C | 1 mL/minute/g liver | NA | ||||||
| Perk et al[29] | 37 °C | Pressure dependent | 10-12 cmH2O | ||||||
| Schlegel et al[30] | 4 °C | Pressure dependent | ≤ 3 mmHg | ||||||
| Bruinsma et al[88] | Room temperature | NA | NA | ||||||
| Liu et al[31] | 20 °C | 1 mL/minute/g | NA | ||||||
| Carnevale et al[93] | 5.0 °C ± 0.5 °C | 0.23 mL/minute/g liver | 40 mmH2O (25% of the NMP PV pressure) | 37 °C | NA | NA | |||
| Schlegel et al[32] | 4 °C | Pressure dependent | ≤ 3 mmHg | ||||||
| Schlegel et al[33] | 4 °C | PV: 1-2 mL/minte | PV: 3 mmHg | 37 °C | HA: 6 mL/minute; PV: 15 mL/minute | PV: 8 mmHg | |||
| Bae et al[34] | 4 °C | 3.5 mL/minute/g of liver | NA | 37 °C | NA | NA | |||
| Niu et al[68] | 37 °C | 20 mL/minute | NA | ||||||
| Tarantola et al[35] | 20 °C | 4 mL/minute/g | NA | 37 °C | 4 mL/minute/g | NA | |||
| Bruinsma et al[36] | 21°C | 8-12 mL/minute | 10-15 cmH2O | ||||||
| Ferrigno et al[37] | 10 °C | 2.6 mL/minute/g | 5.8 ± 0.2 mmHg | 20 °C or 30 °C | 2.6 mL/minute/g | 4.9 ± 0.1 mmHg, 4.9 mmHg ± 0.2 mmHg | 37 °C | 2.6 mL/minute/g | 4.2 ± 0.1 mmHg |
| Jia et al[38] | 4 °C | 1.4 mL/minute | NA | ||||||
| Westerkamp et al[94] | 8 °C | Pressure dependent | PV: 3 mmHg; HA: 25 mmHg | 20 °C | Pressure dependent | PV: 4 mmHg; HA: 40 mmHg | 37 °C | Pressure dependent | PV: 11 mmHg. HA: 110 mmHg |
| Carbonell et al[95] | 22 °C or 26 °C | 3 mL/minute/g | NA | 37 °C | 3 mL/minute/g | NA | |||
| Op den Dries et al[75] | 37 °C | PV: 22.6 ± 0.8 mL/minute; HA: 5.3 ± 0.4 mL/minute | PV: < 11 mmHg. HA: < 110 mmHg | ||||||
| Okamura et al[39] | 20-24 °C | PV: 1 mL/g-liver/minute; HA: 0.1 mL/g-liver/minute | NA | 37 °C | PV: 3 mL/g-liver/minute | NA | |||
| Berardo et al[40] | 20 °C | NA | Starting: 6-7 mmHg | 37 °C | NA | Starting: 6-7 mmHg | |||
| Chai et al[89] | 4 °C | 4 mL/minute | NA | ||||||
| Zeng et al[41] | 0-4 °C | 0.5 mL/g/minute | NA | 36-37 °C | Pressure dependent | 10.3 mmHg | |||
| Beal et al[42] | 37 °C | 1-2 mL/minute | 10-16 cmH2O | ||||||
| Tabka et al[69] | 20 °C | 0.5 mL/g/minute | NA | 37 °C | NA | NA | |||
| Xue et al[43] | 0-4 °C | 0.23 mL/minute/g | NA | 36-37 °C | 3 mL/minute/g | NA | |||
| He et al[78] | 4 °C | 1.4 mL/minute | NA | ||||||
| Gassner et al[70] | 37 °C | 1 mL/minute/g liver weight | 4-9 mmHg | ||||||
| Zeng et al[79] | Approximately 4 °C | 0.2 mL/minute/g | < 2 mmHg | 36.5 °C ± 0.5 °C | 2.5 mL/minute/g | NA | |||
| Jia et al[80] | 4 °C | 1.4 mL/minute | 4.61 mmHg (mean) | ||||||
| Oldani et al[44] | 4 °C | Pressure dependent | 4 mmHg | 37 °C | Pressure dependent | 8 mmHg | |||
| Chin et al[45] | 37 °C | Initial: 5 mL/minute, then pressure dependent | 5 mmHg | ||||||
| Gillooly et al[46] | 4-7 °C | Pressure dependent | 10 mmHg | 37 °C | Pressure dependent | 10 mmHg | |||
| Martins et al[47] | 32 °C or 37 °C | NA | NA | ||||||
| Scheuermann et al[48] | 25 ± 0.1 °C or 30 °C | 1.80 mL/minute/g liver | NA | 37 °C | 1.80 mL/minute/g liver. Reperfusion: 2.84 ± 0.04 mL/minute/g liver | NA | |||
| Claussen et al[71] | 37 °C | PV: 1 mL/minute/g liver. HA: 0.1 mL/minute/g liver | PV: 5.65-9 mmHg. HA: 48.8-110 mmHg | ||||||
| Haque et al[49] | 37 °C | 25-30 mL/minute | < 12 mmHg | ||||||
| Schlegel et al[50] | 10 °C | 1-2 mL/minute | ≤ 3 mmHg | 37 °C | 15-18 mL/minute | 12 mmHg | |||
| Nösser et al[51] | 21 °C | 1 mL/g wet liver/minute | 5.0 mmHg | 37 °C | 1 mL/g wet liver/minute | 5.0 mmHg | |||
| Yamada et al[96] | 20-25 °C | NA | NA | 37 °C | NA | NA | |||
| Hu et al[52] | 0-4 °C | 0.5 mL/g/minute | NA | 36.5 °C ± 0.5 °C | NA | 10.3 mmHg | |||
| Von Horn and Minor[53] | 35-42 °C | NA | Initial: 3 mmHg. Later: 5 mmHg | ||||||
| Raigani et al[54] | 37 °C | NA | 10-12 mmHg | ||||||
| Yang et al[55] | 35-38 °C | 2 mL/g wet liver/minute | 10-12 mmH2O | ||||||
| Westerkamp et al[76] | 37 °C | NA | PV: 11 mmHg. HA: 110 mmHg | ||||||
| De Vries et al[86] | 21 ± 1 °C | ≤ 25 mL/minute | 5 mmHg | ||||||
| Liu et al[85] | 4 °C | PV: 8 mL/minute | NA | 37 °C | PV: 8 mL/minute; HA: 4 mL/minute | NA | |||
| Lin et al[56] | 4 °C | < 0.15 mL/minute/g | < 3 mmHg | ||||||
| Rigo et al[57] | 37 °C | 1.1-1.3 mL/minute/g | 8-10 mmHg | ||||||
| Xu et al[97] | 37 °C | NA | NA | ||||||
| Carlson et al[58] | 37 °C | 1.8 mL/minute/g | NA | ||||||
| Zhou et al[81] | NA | NA | NA | NA | NA | NA | |||
| Cao et al[59] | 36-38 °C | 1.5 mL/minute/g wet liver | 10-14 cmH2O | ||||||
| De Stefano et al[60] | 37 °C | NA | 12-16 mmHg | ||||||
| Sun et al[61] | NA | NA | NA | ||||||
| Jennings et al[62] | 37 °C | 1.8 mL/minute/g | NA | ||||||
| Wang et al[72] | 4 °C | NA | NA | 36.5 ± 0.5 °C | NA | NA | |||
| Asong-Fontem et al[73] | 5 °C ± 3 °C | NA | NA | 37 °C | NA | NA | |||
| Shi et al[77] | 38 °C | PV: 5-15 mL/minute. PV and HA flow ratio 3:1 | PV: 8-10 mmHg. HA: 90-100 mmHg | ||||||
| Von Horn et al[63] | 8 °C | NA | 5 mmHg | 37 °C | 3 mL/g minute | NA | |||
| Zhou et al[82] | NA | NA | NA | NA | NA | NA | |||
| Luo et al[83] | 4 °C | 1.2 mL/minute | NA | 35-37 °C | 2 mL/g/minute | NA | |||
| Ohara et al[64] | 37 °C | PV: 1 mL/minute/g liver. HA: 0.25 mL/minute/g liver | NA | ||||||
| Chen et al[65] | 37 °C | 1 mL/minute | 7-10 mmHg | ||||||
| Fukai et al[74] | 7-10 °C | 0.5 mL/minute/g liver | 4-6 cmH2O | 37 °C | NA | 8-12 cmH2O | |||
| Hughes et al[84] | 36-37.5 °C | PV: 1.2 mL/g-liver/minute; HA: 0.2 mL/g-liver/minute | NA | ||||||
| Bai et al[98] | NA | NA | NA | ||||||
| Von Horn et al[66] | Risen from 8 to 35 °C | 5.5 ± 1.4 mL/g/minute or 5.2 ± 1.1 mL/g/minute | Risen from 3 mmHg to 6 mmHg | 37 °C | 3 mL/g/minute | NA | |||
| Li et al[87] | 37 °C | Pressure dependent | < 4 mmHg | ||||||
- Citation: Bickaite-Bausiene K, Kvietkauskas M, Leber B, Bausys B, Brislinger D, Strupas K, Stiegler P. Small animal ex vivo machine perfusion of the liver: A comprehensive literature review. World J Gastroenterol 2026; 32(9): 111199
- URL: https://www.wjgnet.com/1007-9327/full/v32/i9/111199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i9.111199
